Snowball logo
logo
6035

Ningbo Menovo Pharm Co Ltd

603538 SHG
¥25.81+¥0.39  (1.53%)
Estimate
P/E
67.9
EPS
0.38
Beta
-0.168
Growth
Revenue, YoY
30.02%
Net income, YoY
16.86%
FCF, YoY
836.71%
About the company
Ticker
603538
ISIN
CNE100002Y25
Country
China
Sector (GICS)
Healthcare
Ningbo Menovo Pharmaceutical Co., Ltd. research, develops, produces, and sells pharmaceutical products. The company's products portfolio includes valsartan, losartan, clopidogrel, perindopril, rosuvastatin calcium, atorvastatin calcium, purin bahrain, and other products. It offers APIs, intermediates, and preparations for the treatment of cardiovascular, central nervous system, gastrointestinal tract, and other therapeutic areas. The company was founded in 2004 and is headquartered in Ningbo, China.

Frequently asked questions

What sector does Ningbo Menovo Pharm Co Ltd (603538) operate in?

Ningbo Menovo Pharm Co Ltd belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.

What is Ningbo Menovo Pharm Co Ltd (603538) current stock price?

As of the latest data, Ningbo Menovo Pharm Co Ltd stock price is CN¥25.81, with a previous close of CN¥25.42. Ningbo Menovo Pharm Co Ltd gained CN¥0.39 in the last trading session, representing a 1.53% increase.

What is Ningbo Menovo Pharm Co Ltd (603538) current market capitalization?

Ningbo Menovo Pharm Co Ltd market cap is approximately 8.77 billion.

What is Ningbo Menovo Pharm Co Ltd (603538) Earnings Per Share (EPS)?

The trailing EPS is CN¥0.38.

What is Ningbo Menovo Pharm Co Ltd (603538) Price-to-Earnings (P/E) ratio?

Ningbo Menovo Pharm Co Ltd current P/E ratio is 67.92.

Does Ningbo Menovo Pharm Co Ltd (603538) pay dividends?

No. Ningbo Menovo Pharm Co Ltd does not pay a dividend.

What is Ningbo Menovo Pharm Co Ltd (603538) beta (volatility) score?

Ningbo Menovo Pharm Co Ltd has a beta of -0.168, indicating lower volatility than the overall market.